News

MUSC hosts a New Faculty Research Orientation, providing faculty with essential resources and insights to excel.

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Electronic health record-based screening for intimate partner violence prioritizes confidentiality.

MUSC leaders and the community celebrate faculty achievements in annual recognition event.

Using a novel model for a common fatty liver disease, an MUSC team has identified a pathway that could be targeted to reduce fat accumulation in the liver.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.

MUSC scientists report successful Alaskan expedition for novel therapeutics for pancreatic cancer.

A newly approved targeted therapy for small cell lung cancer is at the forefront of a new type of drug for solid tumors.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.